416 related articles for article (PubMed ID: 10773034)
21. Beta-adrenergic agonist-mediated desensitization in senescent rats.
Scarpace PJ; Abrass IB
Mech Ageing Dev; 1986 Aug; 35(3):255-64. PubMed ID: 2877123
[TBL] [Abstract][Full Text] [Related]
22. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate.
Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP
Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535
[TBL] [Abstract][Full Text] [Related]
23. Putrescine modulation of acute activation of the beta-adrenergic system in the left atrium of rat.
Bordallo C; Cantabrana B; Velasco L; Secades L; Meana C; Méndez M; Bordallo J; Sánchez M
Eur J Pharmacol; 2008 Nov; 598(1-3):68-74. PubMed ID: 18755180
[TBL] [Abstract][Full Text] [Related]
24. Species comparison of adenosine and beta-adrenoceptors in mammalian atrial and ventricular myocardium.
Musser B; Morgan ME; Leid M; Murray TF; Linden J; Vestal RE
Eur J Pharmacol; 1993 Jul; 246(2):105-11. PubMed ID: 8397091
[TBL] [Abstract][Full Text] [Related]
25. beta-Adrenoceptor density and adenylyl cyclase activity in obese rabbit hearts.
Carroll JF; Kyser CK; Martin MM
Int J Obes Relat Metab Disord; 2002 May; 26(5):627-32. PubMed ID: 12032745
[TBL] [Abstract][Full Text] [Related]
26. Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists.
Sulakhe PV; Vo XT; Mainra RR
Mol Cell Biochem; 1997 Nov; 176(1-2):75-82. PubMed ID: 9406147
[TBL] [Abstract][Full Text] [Related]
27. Positive inotropic effects of the beta 2-adrenoceptor agonist terbutaline in the human heart: effects of long-term beta 1-adrenoceptor antagonist treatment.
Schäfers RF; Adler S; Daul A; Zeitler G; Vogelsang M; Zerkowski HR; Brodde OE
J Am Coll Cardiol; 1994 Apr; 23(5):1224-33. PubMed ID: 8144793
[TBL] [Abstract][Full Text] [Related]
28. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
Bristow MR; Hershberger RE; Port JD; Minobe W; Rasmussen R
Mol Pharmacol; 1989 Mar; 35(3):295-303. PubMed ID: 2564629
[TBL] [Abstract][Full Text] [Related]
29. Adenosine receptor-mediated inhibition of cardiac adenylyl cyclase activity may involve multiple receptor subtypes.
Ma H; Yu HJ; Green RD
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):81-6. PubMed ID: 8139704
[TBL] [Abstract][Full Text] [Related]
30. Putative beta 4-adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (-)-[3H]-CGP 12177 binding.
Sarsero D; Molenaar P; Kaumann AJ; Freestone NS
Br J Pharmacol; 1999 Dec; 128(7):1445-60. PubMed ID: 10602323
[TBL] [Abstract][Full Text] [Related]
31. Differential desensitization of A1 adenosine receptor-mediated inhibition of cardiac myocyte contractility and adenylate cyclase activity. Relation to the regulation of receptor affinity and density.
Liang BT; Donovan LA
Circ Res; 1990 Aug; 67(2):406-14. PubMed ID: 2376079
[TBL] [Abstract][Full Text] [Related]
32. Age-related changes in beta-adrenergic neuroeffector systems in the human heart.
White M; Roden R; Minobe W; Khan MF; Larrabee P; Wollmering M; Port JD; Anderson F; Campbell D; Feldman AM
Circulation; 1994 Sep; 90(3):1225-38. PubMed ID: 8087932
[TBL] [Abstract][Full Text] [Related]
33. Regulation of myocardial beta-adrenergic receptor function in adult and neonatal rabbits.
Sun LS
Biol Neonate; 1999 Sep; 76(3):181-92. PubMed ID: 10460955
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of cyclic adenosine monophosphate effluent protein MRP4 induces an altered response to β-adrenergic stimulation in the senescent rat heart.
Carillion A; Feldman S; Jiang C; Atassi F; Na N; Mougenot N; Besse S; Hulot JS; Riou B; Amour J
Anesthesiology; 2015 Feb; 122(2):334-42. PubMed ID: 25383567
[TBL] [Abstract][Full Text] [Related]
35. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
Smith RD; Cobuzzi A; Wolf PS; Pruss TP
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
[TBL] [Abstract][Full Text] [Related]
36. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
37. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog.
Calderone A; Bouvier M; Li K; Juneau C; de Champlain J; Rouleau JL
Circ Res; 1991 Aug; 69(2):332-43. PubMed ID: 1650296
[TBL] [Abstract][Full Text] [Related]
38. Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.
Tanaka H; Shigenobu K
Br J Pharmacol; 1990 May; 100(1):138-42. PubMed ID: 2164856
[TBL] [Abstract][Full Text] [Related]
39. Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulfophenylxanthine-induced hypertension.
Rubino A; Burnstock G
J Pharmacol Exp Ther; 1995 Oct; 275(1):422-8. PubMed ID: 7562580
[TBL] [Abstract][Full Text] [Related]
40. Transregulation of adenylyl-cyclase-coupled inhibitory receptors in heart failure enhances anti-adrenergic effects on adult rat cardiomyocytes.
Borst MM; Szalai P; Herzog N; Kübler W; Strasser RH
Cardiovasc Res; 1999 Oct; 44(1):113-20. PubMed ID: 10615395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
